Companion Diagnostics

Today, it is widely accepted that patients react differently to drugs not only due to factors such as age or weight but also depending on inherent diversities of their genetic makeup. An effective treatment for one person may not work for someone else or may even cause an adverse reaction. Companion diagnostic tests enable the development of new th... erapeutics for particular populations and help doctors customize treatments to achieve the best possible results. Instead of a trial-and-error approach, physicians can immediately choose the most effective medication with the fewest side-effects, while at the same time reducing healthcare costs. In addition, the concept of companion diagnostics opens up new latitudes to ensure value and generate a competitive edge for pharmaceutical and biotech products. With the opportunity to preselect patients for clinical trials, companion diagnostics can help to reduce overall development costs, time and simultaneously increase efficiency and efficacy of a specific drug candidate. Even if a drug is already approved, companion diagnostics may increase market share based on the significantly increased response rate when prescribed to a defined group of patients. R-Biopharm has long-term experience in the development of test systems for clinical diagnostics based on various technology platforms and commercializes innovative diagnostic tests. R-Biopharm offers co-development programs for personalized healthcare as a trusted partner to pharmaceutical and biotechnology companies, enabling and supporting their efforts to bring the most effective personalized therapies to global markets.Read More